LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN
Go back to LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 195.96 +7.13 (3.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $188.83 | 52 Week High | $333.65 | |||
| Open | $187.69 | 52 Week Low | $223.02 | |||
| Day High | $196.51 | P/E | 25.09 | |||
| Day Low | $187.48 | EPS | $7.81 | |||
| Volume | 891,787 | |||||
| Eisai Co Ltd American Depositary Shares (AMEX: ESALY) | Delayed: 61.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $67.60 | |||
| Open | $49.73 | 52 Week Low | $53.55 | |||
| Day High | $61.51 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $0.00 | |||
| Volume | 1,907,007 | |||||
